Physician profile
Ahmad Aref
NPI 1053522540
$179,074.18
in general payments reported to CMS, 2019-2025
16 companies · $27K in 2025
The $27K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $7,804 · 2021: $36K · 2022: $31K · 2023: $31K · 2024: $16K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Honoraria: $15K · Travel and Lodging: $7,707 · Consulting Fee: $7,070 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,400 · Food and Beverage: $3,954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,925.00 |
| Honoraria | $14,800.89 |
| Travel and Lodging | $7,706.64 |
| Consulting Fee | $7,070.10 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,400.00 |
| Food and Beverage | $3,953.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $70,031.20 | 2019-2021 | |
| Alcon Vision LLC | $63,734.07 | 2022-2025 | Rhopressa, Rocklatan, Simbrinza |
| New World Medical,INC. | $19,919.53 | 2019-2025 | Clearpath, Ahmed Glaucoma Valve, Streamline |
| Nova Eye, INC. | $15,133.01 | 2021-2024 | |
| Dompe US, INC. | $4,400.00 | 2023-2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $3,568.25 | 2019 | |
| Oculus Surgical INC. | $1,506.26 | 2021-2023 | Gonio Ready |
| Johnson & Johnson Surgical Vision, INC. | $213.48 | 2023-2025 | Tecnis Iol, Tecnis Simplicity |
| Carl Zeiss Meditec USA, INC. | $130.03 | 2023-2024 | Iolmaster 700 |
| Abbvie INC. | $129.55 | 2022-2024 | Durysta |
| Bausch & Lomb Americas INC. | $111.00 | 2024 | Envista Mx60 Iol, Envista Aspire Iol |
| Ocular Therapeutix, INC. | $93.75 | 2021 | |
| Carl Zeiss Meditec, INC. | $36.11 | 2023 | |
| Allergan, INC. | $32.51 | 2021 | |
| Thea Pharma INC. | $19.08 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $16.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Aref listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.